Filing Details
- Accession Number:
- 0001181431-14-029191
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-14 13:22:27
- Reporting Period:
- 2014-08-13
- Filing Date:
- 2014-08-14
- Accepted Time:
- 2014-08-14 13:22:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 821995 | Columbia Laboratories Inc | CBRX | Pharmaceutical Preparations (2834) | 592758596 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1282199 | Jr Frank Condella | C/O Columbia Laboratories 4 Liberty Square Boston MA 02110 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Cbrx Stock On Open Market | Acquisiton | 2014-08-13 | 10,000 | $5.98 | 55,345 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $5.95 to $6.00. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
